please note VACiRISS and EVIDENCE are presently unpublished
ADAPT Sepsis
Paul Dark (Manchester) delivers the results of the ADAPT‑Sepsis trial at CCR Down Under 2024 at The Edge, Melbourne. An independent editorial is provided by Marion Campbell (Aberdeen). The panelists are Michael Bailey (Melbourne), Naomi Hammond (Sydney), Sandra Peake (Adelaide), and Yaseen Arabi (Riyadh). The session is chaired by Kathy Rowan (London). The ADAPT‑Sepsis trial evaluated biomarker-guided antibiotic duration in hospitalised patients with suspected sepsis.
Manu Shankar-Hari (London) presents the results of the VACIRiSS trial at CCR Down Under 2024 at The Edge, Melbourne. Dr Sarah Sasson (Sydney) delivers an independent editorial. The panelists are Dr Liz Ryan (Melbourne), Dr Chris Seymour (Pittsburgh), Dr Israel Maia (Sao Paulo) adn Prof Steve Webb (Perth). The session is chaired by Dr Lisa Higgins (Melbourne). VACIRiSS investigates the effects of pneumococcal vaccination in sepsis survivors
The first few minutes of audio are missing from this recording. The audio starts at 04:48. We apologise for the inconvenience.
ALBICS AKI
Yahya Shehabi (Melbourne) and Mayu Balachandran (Melbourne) present the results of the ALBICS‑AKI trial at CCR Down Under 2024 at The Edge, Melbourne. An independent editorial is delivered by Tomoko Fujii (Tokyo). The panelists are Victoria Cornelius (London), Naomi Hammond (Melbourne), Rachel Parke (Auckland), and Bala Venkatesh (Brisbane). The session is chaired by Chris Seymour (Pittsburgh). The ALBICS‑AKI trial investigated whether postoperative 20% albumin reduces acute kidney injury in high‑risk cardiac surgery patients.
Shane English (Ottawa) and Anthony Delaney (Ottawa) present the results of the SAHaRA trial at CCR Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Jamie Cooper (Canberra). The panelists are Marion Campbell (Aberdeen), Celia Bradford (Sydney), Lisa Higgins (Melbourne), and Paul Young (Auckland). The session is chaired by Darren Taichman (Philadelphia). The SAHaRA trial examined liberal versus restrictive red blood cell transfusion strategies in patients with aneurysmal subarachnoid hemorrhage.
Jacob Steinmetz (Copenhagen) presents the results of the TRAUMOX2 trial at CCR Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Paul Young (Wellington). The panelists are Victoria Cornelius (London), Carol Hodgson (Melbourne), Brian Burns (Sydney), and John Myburgh (Sydney). The session is chaired by Kathy Rowan (London). The TRAUMOX2 trial investigated restrictive versus liberal oxygen strategies in trauma patients.
Israel Maia (Sao Paulo) presents the results of the RENOVATE trial at CCR Down Under 2024 at The Edge, Melbourne. An independent editorial is delivered by Danny McAuley (Belfast). The panelists are Michael Bailey (Melbourne), Carol Hodgson (Melbourne), Sandra Peake (Adelaide), and Simon Finfer (Sydney). The session is chaired by Andrew Udy (Melbourne). The RENOVATE trial evaluated high-flow nasal cannula versus non-invasive ventilation in acute respiratory failure.
Mark Dennis (Melbourne) and Brian Burns (Sydney) present the results of the EVIDENCE trial at CCR Down Under 2024 at The Edge, Melbourne. An independent editorial is delivered by Stephen Bernard (Melbourne). The panelists are Marion Campbell (Aberdeen), Kiran Shekar (Brisbane), Bridget Dicker (Auckland), and Jacob Steinmetz (Copenhagen). The session is chaired by Chris Nickson (Melbourne). The EVIDENCE trial investigated expediated out-of-hospital cardiac arrest care, including in-hospital ECMO and advanced CPR methods.
Yaseen Arabi (Riyadh) presents the results of the SCREEN trial at CCR Down Under 2024 at The Edge, Federation Square. An independent editorial is delivered by Kathy Rowan (London). The panelists are Liz Ryan (Melbourne), Sarah Sasson (Sydney), Rinaldo Bellomo (Melbourne), and Manu Shankar-Hari (Edinburgh). The session is chaired by Lisa Higgins (Melbourne). The SCREEN trial assessed electronic early notification systems for sepsis detection in hospitalized ward patients.
